CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Michał Szulc - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Michał Szulc

OPENALEX: A5047516625↗ORCID: 0000-0003-3295-2789↗

Affiliations

Organizations

Poznan University of Medical Sciencesauthorship · PL

Public evidence

4 connected articles

Evaluation of Anti-Inflammatory Effects of <i>Cannabis sativa</i> Extracts via Possible Modulation of mRNA Levels of Inflammatory Cytokines and Cannabinoid Receptors.2026 · Europe PMC <i>Cannabis sativa</i> L. Extract Increases COX-1, COX-2 and TNF-α in the Hippocampus of Rats with Neuropathic Pain.2025 · Europe PMC <i>Cannabis sativa</i> L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat.2024 · Europe PMC Cannabidiol as a Modulator of the Development of Alcohol Tolerance in Rats.2023 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.